Suicidal Ideation and Suicide Attempts in Recent-Onset Schizophrenia
|
|
- Nigel Ellis
- 6 years ago
- Views:
Transcription
1 Suicidal Ideation and Suicide Attempts in Recent-Onset Schizophrenia by Alexander S. Young, Keith H. Nuechterlein, Jim Mints, Joseph Ventura, Michael Qitlin, and Robert P. Liberman Abstract The objective of this study was to predict suicidality in people with schizophrenia. Ninety-six patients with recent-onset schizophrenia were rated every 2 weeks for 1 year to examine (1) the temporal course of suicidal ideation and suicide attempts and (2) the extent to which anxiety, depression, and mild suicidal ideation were followed by significant suicidal ideation or a suicide attempt. The severity of suicidality changed rapidly. Low levels of suicidal ideation increased the risk for significant suicidal ideation or a suicide attempt during the subsequent 3 months. Depression was moderately correlated with concurrent suicidality, but not independently associated with future suicidality. Therefore, low levels of suicidal ideation may predict future suicidal ideation or behavior better than depressed mood in individuals with schizophrenia. Key words: Suicidal ideation, depression, anxiety. Schizophrenia Bulletin, 24(4): ,1998. Suicide remains a tragically common outcome in people with schizophrenia. In fact, about 10 percent of all people with this disorder die by suicide (Allebeck 1989; Roy 1992). Completed suicides have long-lasting effects on families and clinicians, and suicidal ideation and attempts place stress on the people and systems that provide care for individuals with schizophrenia (Rissmiller et al. 1994). As in other psychiatric disorders, no method exists for predicting suicide in any individual case of schizophrenia (Goldstein et al. 1991; Caldwell and Gottesman 1992). Researchers have, however, characterized individuals who are generally at higher risk of suicide. Retrospective case reviews and large followup studies have identified risk factors for suicide in schizophrenia, including being young and male, being in the first decade of illness, having a high level of premorbid functioning, and having multiple relapses (Caldwell and Gottesman 1990; Rossau and Mortensen 1997). Most studies have not, however, provided a detailed assessment of clinical status before attempted or completed suicide. It is just this clinical information that would be most useful for predicting, intervening, and preventing suicide attempts (Liberman and Eckman 1981; Linehan et al. 1991). Although it is known that individuals who commit suicide often have a previous history of suicide attempts and depressive symptoms, the predictive value of these markers is unclear (Drake et al. 1985). We do not know, for instance, whether these markers identify a state of depression or traits of individuals who are more vulnerable to suicidal behavior (Schotte and Clum 1987; Mann and Arango 1992). The known demographic and clinical risk factors for suicide identify a large population of individuals, many of whom will be at increased risk throughout years of treatment in community settings. More specific clinical indicators might be developed through a better understanding of the time period of increased risk conferred by each clinical risk factor. In this study, we repeatedly evaluated depression, anxiety, and suicidality over a 1-year period to examine (1) the temporal course of suicidal ideation and suicide attempts and (2) the extent to which anxiety, depression, and mild suicidal ideation are followed by significant suicidal ideation or a suicide attempt. Methods Subjects were participants in an intensive longitudinal project examining symptoms, neurocognitive and psychophysiological processes, psychosocial functioning, and environmental stressors in patients with recent-onset schizophrenia. This project and its sample selection crite- Reprint requests should be sent to Dr. A.S. Young, Dept. of Psychiatry, UCLA Neuropsychiatric Institute, 300 UCLA Medical Plaza, Box , Los Angeles, CA
2 Schizophrenia Bulletin, Vol. 24, No. 4, 1998 A.S. Young et al. ria have been described in detail elsewhere (Nuechterlein et al. 1992). Subjects met the following criteria: (1) first onset of a psychotic disorder within 2 years before project entry; (2) diagnosis by Research Diagnostic Criteria (Spitzer et al. 1978) of schizophrenia or schizoaffective disorder, mainly schizophrenia; (3) age between 18 and 45 years; (4) no evidence of significant and habitual substance abuse in the past 6 months; and (5) no evidence that substance abuse triggered the psychotic episode. Twenty-nine potential subjects were excluded because they had significant and habitual substance abuse during the 6 months before screening or substance abuse that may have triggered their psychosis. Eighty-one percent of subjects were male; 86 percent were Anglo, 6 percent Latino, 3 percent Asian, and 4 percent other. At project entry, the mean age was 23.4 years (range, 18 to 43). Educational level was defined as the highest grade completed at project entry and averaged 12.5 years (range, 8 to 20). Social class for family of origin was assessed using the Hollingshead Two-Factor Index of Social Position (Hollingshead 1971), which is scored from 1 (highest) to 5 (lowest). There were 13 subjects in social class 1, 22 in class 2, 21 in class 3, 34 in class 4, and 5 in class 5 (mean class = 3.0, standard deviation [SD] = 1.2). One of the 96 subjects had missing social class data. Total duration of illness was defined as the number of months since the onset of any prodrome or symptoms, and averaged 15.8 months at project entry. Structured diagnostic assessment determined that 24 subjects had schizophreniform disorder, 62 had schizophrenia, and 10 had schizoaffective disorder according to DSM-HI-R criteria (American Psychiatric Association 1987). All subjects gave written informed consent after the study had been fully explained. Subjects received their mental health treatment through the Aftercare Program, a research clinic at University of California Los Angeles (UCLA). A multidisciplinary treatment team provided case management, socialization activities, and patient and family education. Medication management included a standard starting dosage of fluphenazine decanoate (12.5 mg every 2 weeks) with dosage changes for intolerable side effects and significant symptoms. Adjunctive psychotropic medications (e.g., antidepressants) were used as clinically needed. Subjects were typically seen weekly at the Aftercare Program for the first few weeks after entry, and then every other week on an ongoing basis. A psychiatrist monitored clinical symptoms, prescribed medication, and provided medical supervision for each subject. Social workers and psychologists served as individual case managers and cotherapists for group therapy that emphasized problem-solving strategies and training in social skills. Family education involved a 3- to 4-hour session led by multiple clinical staff for groups of new families. Followup sessions with individual families were provided as clinically indicated. This study examines the first year after subjects were stabilized on outpatient medication in the research clinic. Ratings for this study begin 1 month after the starting outpatient medication dosage was reached, that is, an average of 3 months after subjects entered the research project. Case managers rated anxiety, depression, and suicidal ideation and behavior using the Expanded UCLA version of the Brief Psychiatric Rating Scale (BPRS; Ventura et al. 1993), which is an adaptation of the original BPRS (Overall and Gorham 1962). Mean intraclass correlation coefficients with criterion ratings were between 0.89 and The Expanded BPRS includes explicit anchor points for each rating level from "not present" (1) to "extremely severe" (7), and an item developed at our Center to assess suicidality. The suicidality item instructs the interviewer to ask specifically about suicidal ideation and behavior at each interview and uses anchor points derived from prior indicators of severity (Pallis et al. 1982). Suicidality ratings below moderate (< 4) include anchors such as "occasional feelings of being tired of living" that may not reach the threshold for clinical attention or treatment in many clinical settings. Ratings of moderate (4) and moderately severe (5) identify subjects who frequently consider suicide or make a suicide attempt with low lethality. Ratings of severe (6) and extremely severe (7) identify subjects who clearly want to kill themselves or who make a suicide attempt of high lethality. For these analyses, "significant suicidality" was defined as a rating of moderate or higher and "low-level suicidality" as a rating of very mild or mild. Thus, "significant suicidality" included either frequent suicidal ideation or any suicidal behavior. Similarly, "significant depression" and "significant anxiety" indicate a rating of moderate or higher on the relevant item. BPRS ratings were repeated about every 2 weeks for 1 year and were based on symptoms and behaviors since the previous assessment. Associations between ratings of suicidality and depression were evaluated using concurrent and lagged correlations. Analyses were done by performing crosscorrelation analyses within subjects and then pooling results across subjects for significance testing. First, a simple Pearson r was computed within each subject's repeated scores. These correlations were z-transformed, weighted by their squared standard errors, and averaged across subjects. The significance of the resulting average was evaluated with reference to a normal curve test (Fleiss 1981). Because of autocorrelation in these time series (i.e., ratings at a given visit were correlated with those at the next visit), statistical analysis of the significance of these correlations required time series analyses. 630
3 Suicidal Ideation in Recent-Onset Schizophrenia Schizophrenia Bulletin, Vol. 24, No. 4, 1998 These were performed using conventional time series regression models (Box and Jenkins 1976) computed with SAS (SAS User's Guide 1989) procedure ARIMA. We examined both first-degree autoregressive and moving average models. Results were essentially equivalent, and only the former are presented. Risk analyses were performed using survival regression models (Cox and Oakes 1984) computed with the SAS procedure PHREG. The criterion was a suicidality score of moderate or above. At-risk indicators of low-level suicidality and significant depression were included as time-varying covariates. Results Ninety-six subjects were rated on the Expanded BPRS at approximately 2-week intervals for up to 1 year. Eightythree subjects were rated for at least 40 weeks, with an average of 18.5 ratings per subject. The number of ratings per subject ranged from 2 to 28, with only 11 subjects having fewer than 10 ratings. Subjects who left the project early had relatively few ratings, and ratings were completed more frequently when clinically indicated. Overall, 2 percent of suicidality ratings, 13.6 percent of depressed mood ratings, and 10.2 percent of anxiety ratings were at the moderate level or above. Of the 96 subjects in the sample, 51 rated at "not present" on the suicidality item at every assessment during the year. Twelve subjects were significantly suicidal at one or more times during the year. In 11 subjects, this consisted of suicidal ideation without a suicide attempt. One subject had two suicide attempts of relatively low lethality. There were no deaths from suicide. Thus, "significant suicidality" in this report refers to clinical levels of suicidal ideation and, for one subject, nonlethal suicide attempts. Table 1 presents the rate of significant suicidality by subject gender, age, ethnicity, education, social class, diagnosis, and length of illness. The statistical power to detect differences was limited, and no significant differences were found at the p < 0.05 level. Very few episodes of suicidality had a distinct onset, plateau, and offset. Instead, the level of suicidality changed rapidly. Thirty-two rating periods included ratings of significant suicidality. Of these, 7 were increases from "not present," 6 were increases from "very mild," 9 were increases from "mild," and the remaining 10 were a continuation of previous significant suicidality. Conversely, 0.7 percent of "not present" ratings, 6.8 percent of "very mild" ratings, and 19.1 percent of "mild" ratings were followed by significant suicidality. Most instances of ideation were not followed by a suicide attempt in this sample. Ratings from the 12 subjects with significant suicidality were examined visually. All 12 had suicidality ratings Table 1. Presence of significant suicidality by demographic characteristic Gender Female (n = 18) Male (n = 78) Age 22 years and younger (n = 49) Older than 22 years (n = 47) Ethnicity Minority (n= 13) Anglo-American (n = 83) Education completed High school graduate or less (n = 62) Beyond high school (n = 34) Social class Lower (class 4 or 5; n = 39) Higher (class 1, 2, or 3; n = 56) Diagnosis (DSM-III-R) Schizophreniform (n = 24) Schizophrenia (n = 62) Schizoaffective (n = 10) Months of illness at admisslor to study 2 12 months or fewer (n = 45) Subjects with significant suicidality (%) s l More than 12 months (n = 51) Note. DSM-III-R = Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised (American Psychiatric Association 1987). 1 No differences are significant at the p < 0.05 level. 2 Lifetime number of months with either prodromal symptoms or characteristic schizophrenic symptoms. of very mild or higher (a 2) on at least one other occasion, and most had numerous occurrences of suicidality over a range of severity levels. Ratings from two subjects are graphed in figure 1. As in subject 1, most subjects had concurrent depressed mood when they were suicidal. However, one individual (subject 2) did not have concurrent depression when suicidal. We used time series analyses to test a conceptual model predicting that current suicidality would be associated with (1) depressed mood at the current assessment, (2) suicidality at the previous assessment, and (3) depressed mood at the previous assessment (mediated through an effect on depressed mood at the current assessment). Thirty-six subjects had variability on both the sui- 631
4 Schizophrenia Bulletin, Vol. 24, No. 4, 1998 A.S. Young et al. Figure 1. Expanded BPRS ratings for one subject with concurrent suicidaiity and depression and one subject without concurrent suicidaiity and depression S RATINQ m SUBJECT 1 [ 44, t I SUICIDALITY! DEPRESSED MOOD WEEK BPRS = Brief Psychiatric Rating Scale-Expanded (Ventura et al. 1993). cidality and depression scales. A moderate concurrent correlation, averaging 0.41 across subjects, was found between suicidaiity and depression. The lagged correlation between one depression rating and the subsequent suicidaiity rating averaged 0.12 across subjects. The time series analysis revealed that the concurrent relationship between depression and suicidaiity was significant (z = 2.55, p = 0.01). However, the lagged relationship was clearly not significant (z = 0.50, p = 0.62). Thus, suicidaiity was significantly associated with depression at the same clinic visit, but not with depression at the previous visit. The above procedures were repeated for anxiety and suicidaiity, and no significant effects were found. We used survival models to test the prognostic significance of depressed mood and low-level suicidal ideation. The criterion was a "significant" suicidaiity rating of moderate or greater. Subjects were defined as at-risk from suicidaiity after they had a low-level suicidaiity rating of very mild or mild. Subjects were defined as at-risk from depression after they had a depressed mood rating of moderate or greater. The ability of each of these two warning flags to predict subsequent significant suicidaiity ratings was assessed for time durations of risk varying from 2 to 52 weeks. s presented in table 2 demonstrate that low-level suicidal ideation was a highly significant predictor. Once a subject displayed low-level ideation, the risk of a subsequent occurrence of a significant suicidaiity rating increased on the order of 20- to 30- fold. When this warning flag was examined as a test, the sensitivity increased from 25 percent at 2 weeks to a maximum of 67 percent at 12 weeks. Sensitivity calculations indicate the percentage of subjects with significant suicidaiity whose first episode of significant suicidaiity was preceded by one or more ratings of low-level suicidaiity. Twelve weeks was the optimal "window" duration for identifying at-risk subjects on the basis of low-level suicidal ideation. Depressed mood did not have a statistically significant effect on subsequent significant suicidaiity (table 2). Any increase appeared to be attributable to the concurrent correlation between depression and suicidaiity. However, low-level suicidaiity increased the odds of a subsequent significant suicidaiity rating even after controlling for depression. Of the 34 subjects who had the onset of very mild or mild suicidal ideation, 24 percent went on to develop significant suicidaiity within 9 weeks. After this Table 2. Time interval (weeks) p< p < p< Risk of significant suicidaiity after depression and suicidal ideation Risk from depression controlling for suicidaiity Sensitivity (%) Risk from suicidal ideation controlling for depression J
5 Suicidal Ideation in Recent-Onset Schizophrenia Schizophrenia Bulletin, Vol. 24, No. 4, 1998 interval, no further significant suicidality was observed. Of the 12 subjects who developed significant suicidal ideation or made a suicide attempt, 8 had very mild or mild suicidal ideation within the previous 9 weeks. Discussion Our results demonstrate that (1) the severity of suicidality changed rapidly, and suicidality did not occur in apparent episodes; (2) the probability of future significant suicidal ideation or behavior was predicted by low-level suicidal ideation, but not by anxiety or depression; and (3) subjects with low-level suicidal ideation continued to have an increased chance of significant suicidal ideation or a suicide attempt for about 3 months. These results suggest that previous findings of an association between depressed mood and subsequent suicidal behavior may be due to concurrent suicidality. While suicidality and depression often co-occur, it appears that only suicidal ideation predicts future suicidal ideation or behavior. Also, the at-risk window after suicidality may be shorter than the 1-year period that previous retrospective studies have emphasized. This study has several potential limitations. First, completed suicide, suicide attempts, and suicidal ideation are clearly not equivalent. The suicidality in this patient population consisted almost entirely of mild to severe suicidal ideation. Therefore, we cannot assume that our findings apply to individuals who make suicide attempts or die by suicide. However, there is evidence that suicidal ideation and behavior can be viewed along a continuum (Beck et al. 1974; Murphy et al. 1992), suggesting that risk factors for significant suicidality might also identify individuals at risk for completed suicide (Pallis et al. 1984). Second, the subjects in this study were treated in a clinic that provided frequent assessment and more intensive care than that offered by many community clinics (Young et al. 1998). This study also excluded people with a significant recent history of substance abuse at the time of screening for project admission; this group may be at increased risk for suicide. Either of these may have lowered the rate of suicidality and reduced our ability to detect effects that might be seen in another sample. Third, depression and anxiety are just two components of the depressive syndrome. Other components, such as demoralization and hopelessness, may have more predictive power (Beck et al. 1990). However, the study from which these data were drawn was not designed with a specific aim of predicting suicidality and did not include assessment of these items. The effects seen in this sample were strong and consistent with previous studies of suicide in large populations (Caldwell and Gottesman 1990). This has several implications. First, clinicians should be aware that suicidality can change rapidly in people with recent-onset schizophrenia. We observed that severity can change markedly from week to week and could not exclude the possibility that it changes daily. Therefore, clinical interventions that are based on detecting suicidality may need to either identify a subgroup of patients with schizophrenia who are at increased risk for suicidal ideation or behavior and monitor this subgroup on a daily or weekly basis and/or encourage all patients with schizophrenia to report suicidal ideation and behavior immediately and create a system that makes it easy for them to do so. Second, we found that mild suicidal ideation can have prognostic significance. Low levels of ideation may predict future ideation or behavior better than depressed mood in schizophrenia. Also, it is likely that mild suicidality would often have been unknown to us had we not specifically asked about it. Although suicidal patients were often depressed, this was not always the case. Clinicians should consider specifically asking patients with schizophrenia about recent suicidal ideation and behavior and could make this assessment using a structured instrument such as the BPRS. Finally, we found a relatively brief period (9 weeks) during which people with suicidal ideation are at increased risk. If replicated in other samples, this suggests a need for evaluating assessment and treatment interventions that focus on this specific period of increased risk. References Allebeck, P. Schizophrenia: A life-shortening disease. Schizophrenia Bulletin, 15(l):81-89, American Psychiatric Association. DSM-IH-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. revised. Washington, DC: The Association, Beck, A.T.; Brown, G.; Berchick, R.J.; Stewart, B.L.; and Steer, R.A. Relationship between hopelessness and ultimate suicide: A replication with psychiatric outpatients. American Journal of Psychiatry, 147: , Beck, A.T.; Resnik, H.L.P.; and Lettieri, D.J., eds. The Prediction of Suicide. Bowie, MD: Charles Press, Box, G.E.P., and Jenkins, G.M. Time Series Analysis: Forecasting and Control. San Francisco, CA: Holden- Day, Caldwell, C.B., and Gottesman, I.I. Schizophrenics kill themselves too: A review of risk factors for suicide. Schizophrenia Bulletin, 16(4): , Caldwell, C.B., and Gottesman, I.I. Schizophrenia A high-risk factor for suicide: Clues to risk reduction. Suicide and Life-Threatening Behavior, 22: ,
6 Schizophrenia Bulletin, Vol. 24, No. 4, 1998 A.S. Young et al. Cox, D.R., and Oakes, D. Analysis of Survival Data. London, England: Chapman and Hall, Drake, R.E.; Gates, C; Whitaker, A.; and Cotton, P.G. Suicide among schizophrenics: A review. Comprehensive Psychiatry, 26:90-100, Fleiss, J.L. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons, Goldstein, R.B.; Black, D.W.; Nasrallah, A.; and Winokur, G. The prediction of suicide: Sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Archives of General Psychiatry, 48: , Hollingshead, A.B. Commentary on "the indiscriminate state of social class measurement." Social Forces, 49: , Liberman, R.P., and Eckman, T. Behavior therapy vs. insight-oriented therapy for repeated suicide attempters. Archives of General Psychiatry, 38: , Linehan, M.M.; Armstrong, H.E.; Suarez, A.; Allmon, D.; and Heard, H.L. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48: , Mann, J.J., and Arango, V. Integration of neurobiology and psychopathology in a unified model of suicidal behavior. Journal of Clinical Psychopharmacology, 12:2S-7S, Murphy, G.E.; Wetzel, R.D.; Robins, E.; and McEvoy, L. Multiple risk factors predict suicide in alcoholism. Archives of General Psychiatry, 49: , Nuechterlein, K.H.; Dawson, M.E.; Gitlin, M; Ventura, J.; Goldstein, M.J.; Snyder, K.S.; Yee, CM.; and Mintz, J. Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress. Schizophrenia Bulletin, 18(3): , Overall, J.E., and Gorham, D.R. The Brief Psychiatric Rating Scale. Psychological Reports, 10: , Pallis, D.J.; Barraclough, B.M.; Levey, A.B.; Jenkins, J.S.; and Sainsbury, P. Estimating suicide risk among attempted suicides: I. The development of new clinical scales. British Journal of Psychiatry, 141:37^4, Pallis, D.J.; Gibbons, J.S.; and Pierce, D.W. Estimating suicide risk among attempted suicides: JJ. Efficiency of predictive scales after the attempt. British Journal of Psychiatry, 144: , Rissmiller, D.J.; Steer, R.; Ranieri, W.F.; Rissmiller, R; and Hogate, P. Factors complicating cost containment in the treatment of suicidal patients. Hospital and Community Psychiatry, 45: , Rossau, CD., and Mortensen, P.B. Risk factors for suicide in patients with schizophrenia: Nested case-control study. British Journal of Psychiatry, 171: , Roy, A. Suicide in schizophrenia. International Review of Psychiatry, 4: , SAS User's Guide: Statistics. 4th ed. Cary, NC: SAS Institute, Schotte, D.E., and Clum, G.A. Problem-solving skills in suicidal psychiatric patients. Journal of Consulting and Clinical Psychology, 55:49-54, Spitzer, R.L., Endicott, J.; and Robins, E. Research Diagnostic Criteria: Rationale and reliability. Archives of General Psychiatry, 35: , Ventura, J.; Lukoff, D.; Nuechterlein, K.H.; Liberman, R.P.; Green, M.F.; and Shaner, A. Brief Psychiatric Rating Scale (BPRS) expanded version (4.0): Scales, anchor points, and administration manual. International Journal of Methods in Psychiatric Research, 3: , Young, A.S.; Sullivan, G.; Burnam, M.A.; and Brook, R.H. Measuring the quality of outpatient treatment for schizophrenia. Archives of General Psychiatry, 55: , Acknowledgments Dr. Young's work on this study was supported by a National Alliance for Research on Schizophrenia and Depression Daniel X. Freedman Young Investigator Award. The longitudinal research project was supported by USPHS grant MH from the National Institute of Mental Health (NIMH) to Dr. Nuechterlein. Diagnostic and symptom assessment training and the data analyses were supported by NIMH Clinical Research Center grant MH (to Dr. Liberman, Principal Investigator). The authors thank Sun Hwang for her contributions to the data analyses. The Authors Alexander S. Young, M.D., M.S.H.S., is Assistant Clinical Professor, Department of Psychiatry; Keith H. Nuechterlein, Ph.D., is Professor, Departments of Psychiatry and Psychology; Jim Mintz, Ph.D., is Professor, Department of Psychiatry; Joseph Ventura, Ph.D., is Assistant Research Psychologist, Department of Psychiatry; Michael Gitlin, M.D., is Clinical Professor, Department of Psychiatry; and Robert P. Liberman, M.D., is Professor, Department of Psychiatry, all at the University of California, Los Angeles, CA. 634
Supplementary Online Content
Supplementary Online Content Subotnik KL, Casaus LR, Ventura J, et al. Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia:
More informationINVESTIGATOR INITIATED RESEARCH PROTOCOL
INVESTIGATOR INITIATED RESEARCH PROTOCOL Study Title: Effects of Risperdal Consta versus oral antipsychotic medication on clinical and functional outcome and neurocognition in first-episode schizophrenia
More informationParacontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits
Schizophrenia Research 71 (2004) 485 492 www.elsevier.com/locate/schres Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits Yuri Rassovsky a,b, *, Michael
More informationHopelessness Predicts Suicide Ideation But Not Attempts: A 10-Year Longitudinal Study
Suicide and Life-Threatening Behavior 1 2017 The American Association of Suicidology DOI: 10.1111/sltb.12328 Hopelessness Predicts Suicide Ideation But Not Attempts: A 10-Year Longitudinal Study TIANYOU
More informationExpressed Emotion, Attributions, and Schizophrenia Symptom Dimensions
Journal of Abnormal Pswholog 1998, \bl. 107. No. 2. 355-35! Copyright 1998 by the American Psychological Association, Inc. 0021-S43X/98/$3.00 Expressed Emotion, Attributions, and Schizophrenia Symptom
More informationProspective assessment of treatment use by patients with personality disorders
Wesleyan University From the SelectedWorks of Charles A. Sanislow, Ph.D. February, 2006 Prospective assessment of treatment use by Donna S. Bender Andrew E. Skodol Maria E. Pagano Ingrid R. Dyck Carlos
More informationCondensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia
Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.
More informationDealing with Feelings: The Effectiveness of Cognitive Behavioural Group Treatment for Women in Secure Settings
Behavioural and Cognitive Psychotherapy, 2011, 39, 243 247 First published online 30 November 2010 doi:10.1017/s1352465810000573 Dealing with Feelings: The Effectiveness of Cognitive Behavioural Group
More informationClinical experience suggests. Ten-Year Use of Mental Health Services by Patients With Borderline Personality Disorder and With Other Axis II Disorders
Ten-Year Use of Mental Health Services by Patients With Borderline Personality Disorder and With Other Axis II Disorders Susanne Hörz, Dipl.-Psych., Ph.D. Mary C. Zanarini, Ed.D. Frances R. Frankenburg,
More informationBRIEF REPORT FACTORS ASSOCIATED WITH UNTREATED REMISSIONS FROM ALCOHOL ABUSE OR DEPENDENCE
Pergamon Addictive Behaviors, Vol. 25, No. 2, pp. 317 321, 2000 Copyright 2000 Elsevier Science Ltd. Printed in the USA. All rights reserved 0306-4603/00/$ see front matter PII S0306-4603(98)00130-0 BRIEF
More informationTHREE YEAR OUTCOMES IN AN EARLY INTERVENTION SERVICE FOR PSYCHOSIS IN A MULTICULTURAL AND MULTIETHNIC POPULATION
Psychiatria Danubina, 2008; Vol. 20, No 4, pp 494 499 Medicinska naklada - Zagreb, Croatia Original paper THREE YEAR OUTCOMES IN AN EARLY INTERVENTION SERVICE FOR PSYCHOSIS IN A MULTICULTURAL AND MULTIETHNIC
More informationOffice Practice Coding Assistance - Overview
Office Practice Coding Assistance - Overview Three office coding assistance resources are provided in the STABLE Resource Toolkit. Depression & Bipolar Coding Reference: n Provides ICD9CM and DSM-IV-TR
More informationThe Link between Marijuana &
The Link between Marijuana & mental illness A Survey of Recent Research OFFICE OF NATIONAL DRUG CONTROL POLICY EXECUTIVE OFFICE OF THE PRESIDENT July 2007 TABLE OF CONTENTS Overview of Marijuana and Mental
More informationSuicide Risk and Melancholic Features of Major Depressive Disorder: A Diagnostic Imperative
Suicide Risk and Melancholic Features of Major Depressive Disorder: A Diagnostic Imperative Robert I. Simon, M.D.* Suicide risk is increased in patients with Major Depressive Disorder with Melancholic
More informationOUR TEAM OUR SPECIALIZED PROGRAMS
OUR TEAM Gracie Square Hospital offers a multidisciplinary approach to care for patients with psychiatric disorders who can benefit from inpatient hospitalization. Our treatment programs are provided by
More informationDiagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample
Available online at www.sciencedirect.com Drug and Alcohol Dependence 96 (2008) 187 191 Short communication Diagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample Lara A.
More informationDeveloping bipolar disorder. A study among children of patients with bipolar disorder Hillegers, Manon Hubertine Johanna
University of Groningen Developing bipolar disorder. A study among children of patients with bipolar disorder Hillegers, Manon Hubertine Johanna IMPORTANT NOTE: You are advised to consult the publisher's
More informationCourse and Outcome for Schizophrenia Versus Other Psychotic Patients: A Longitudinal Study
Course and Outcome for Schizophrenia Versus Other Psychotic Patients: A Longitudinal Study Abstract by Martin Harrow, James R. Sands, Marshall L. Silverstein, and Joseph F. Qoldberg We studied 276 patients
More informationNew Research in Depression and Anxiety
New Research in Depression and Anxiety Robert Glassman Introduction Depression and anxiety are some of the most common disorders of childhood and adolescence. New research in these areas explores important
More informationMEDICAL POLICY EFFECTIVE DATE: 04/28/11 REVISED DATE: 04/26/12, 04/25/13, 04/24/14, 06/25/15, 06/22/16, 06/22/17
MEDICAL POLICY SUBJECT: STANDARD DIALECTICAL BEHAVIOR A nonprofit independent licensee of the BlueCross BlueShield Association PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered,
More informationDevelopmental Processes in Schizophrenic Disorders: Longitudinal Studies of Vulnerability and Stress
VOL. 18, NO. 3, 1992 Developmental Processes in Schizophrenic Disorders: Longitudinal Studies of Vulnerability and Stress 387 by Keith H. Nuechterlein, Michael E. Dawson, Michael Gitlin, Joseph Ventura,
More informationII3B GD2 Depression and Suicidality in Human Research
Office of Human Research Protection University of Nevada, Reno II3B GD2 Depression and Suicidality in Human Research Overview Research studies that include measures for depression and suicidality should
More informationSuboptimal Response in Psychotic & Mood Disorders: Causes, Consequences, and Management Strategies
Suboptimal Response in Psychotic & Mood Disorders: Causes, Consequences, and Management Strategies Henry A. Nasrallah, MD Sydney W. Souers Professor and Chair, Department of Psychiatry, Saint Louis University,
More informationSuccessful Treatments for Early Psychosis: Consistent Antipsychotic Use, Supportive Education/Employment, Cognitive Training, and Aerobic Exercise
Successful Treatments for Early Psychosis: Consistent Antipsychotic Use, Supportive Education/Employment, Cognitive Training, and Aerobic Exercise Keith H. Nuechterlein, Ph.D. Distinguished Professor UCLA
More informationVerbal Interactions in the Families of Schizophrenic and Bipolar Affective Patients
Page 1 of 16 Journal of Abnormal Psychology May 1995 Vol. 104, No. 2, 268-276 1995 by the American Psychological Association For personal use only--not for distribution. Verbal Interactions in the Families
More informationReferral trends in mental health services for adults with intellectual disability and autism spectrum disorders
Referral trends in mental health services for adults with intellectual disability and autism spectrum disorders autism 2007 SAGE Publications and The National Autistic Society Vol 11(1) 9 17; 070987 1362-3613(200701)11:1
More informationOUTCOMES OF DICHOTOMIZING A CONTINUOUS VARIABLE IN THE PSYCHIATRIC EARLY READMISSION PREDICTION MODEL. Ng CG
ORIGINAL PAPER OUTCOMES OF DICHOTOMIZING A CONTINUOUS VARIABLE IN THE PSYCHIATRIC EARLY READMISSION PREDICTION MODEL Ng CG Department of Psychological Medicine, Faculty of Medicine, University Malaya,
More informationCourse syllabus. Psychodynamic and cognitive-behavioral models of mental disorders.
Course syllabus Course title Instructor s name Contact details Affiliation Course format Psychodynamic and cognitive-behavioral models of mental disorders. Agnieszka Chrzczonowicz Stępień, Ph.D. ag.chrzczonowicz@gmail.com
More informationUnderstanding Dialectical Behavior Therapy
Understanding Dialectical Behavior Therapy Midwest Conference on Problem Gambling & Substance Abuse Amy M. Shoffner, Psy.D., Clinical Psychologist June 8, 2012 Development of DBT: Marsha M. Linehan Initially,
More informationPanic disorder and anxiety symptoms are hypothesized
Article Anxiety in Major Depression: Relationship to Suicide Attempts Giovanni P.A. Placidi, M.D. Maria A. Oquendo, M.D. Kevin M. Malone, M.D. Beth Brodsky, Ph.D. Steven P. Ellis, Ph.D. J. John Mann, M.D.
More informationPsychotropic Medication
FOM 802-1 1 of 10 OVERVIEW The use of psychotropic medication as part of a child s comprehensive mental health treatment plan may be beneficial and should include consideration of all alternative interventions.
More informationNeuRA Obsessive-compulsive disorders October 2017
Introduction (OCDs) involve persistent and intrusive thoughts (obsessions) and repetitive actions (compulsions). The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) defines
More informationSupplementary Online Content
Supplementary Online Content Hafeman DM, Merranko J, Goldstein TR, et al. Assessment of a person-level risk calculator to predict new-onset bipolar spectrum disorder in youth at familial risk. JAMA Psychiatry.
More informationTHE HAMILTON Depression Rating Scale
Reliability and Validity of the Turkish Version of the Hamilton Depression Rating Scale A. Akdemir, M.H. Türkçapar, S.D. Örsel, N. Demirergi, I. Dag, and M.H. Özbay The aim of the study was to examine
More informationChallenges to Recovery Following Early Psychosis: Implications of Recovery Rate and Timing
Challenges to Recovery Following Early Psychosis: Implications of Recovery Rate and Timing Mental Health Exchange Group December 3, 2014 W Joy Maddigan, PhD RN Background One component [the quantitative
More informationChange in resolved plans and suicidal ideation factors of suicidality after participation in an intensive outpatient treatment program
Journal of Affective Disorders 103 (2007) 63 68 www.elsevier.com/locate/jad Research report Change in resolved plans and suicidal ideation factors of suicidality after participation in an intensive outpatient
More informationThe Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
Original Article pissn 1738-1088 / eissn 2093-4327 Clinical Psychopharmacology and Neuroscience 2011;9(3):117-121 Copyrightc 2011, Korean College of Neuropsychopharmacology The Diagnostic Stability of
More informationDSM5: How to Understand It and How to Help
DSM5: How to Understand It and How to Help Introduction: The DSM5 is a foreign language! Three Questions: I. The first was, What the key assumptions made to determine the organization of the DSM5? A. Mental
More informationCHAPTER 2 CRITERION VALIDITY OF AN ATTENTION- DEFICIT/HYPERACTIVITY DISORDER (ADHD) SCREENING LIST FOR SCREENING ADHD IN OLDER ADULTS AGED YEARS
CHAPTER 2 CRITERION VALIDITY OF AN ATTENTION- DEFICIT/HYPERACTIVITY DISORDER (ADHD) SCREENING LIST FOR SCREENING ADHD IN OLDER ADULTS AGED 60 94 YEARS AM. J. GERIATR. PSYCHIATRY. 2013;21(7):631 635 DOI:
More informationPsychological and Psychosocial Treatments in the Treatment of Borderline Personality Disorder
Psychological and Psychosocial Treatments in the Treatment of Borderline Personality Disorder The Nice Guidance for the Psychological and Psychosocial treatment of Borderline Personality Disorder (BPD)
More informationDynamic Deconstructive Psychotherapy
This program description was created for SAMHSA s National Registry for Evidence-based Programs and Practices (NREPP). Please note that SAMHSA has discontinued the NREPP program and these program descriptions
More informationSelf-mutilation is deliberate self-harm without the intent
Article Are Suicide Attempters Who Self-Mutilate a Unique Population? Barbara Stanley, Ph.D. Marc J. Gameroff, M.A. Venezia Michalsen, B.A. J. John Mann, M.D. Objective: Individuals who mutilate themselves
More informationBADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0)
BADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0) General information The Bipolar Affective Disorder Dimension Scale (BADDS) has been developed in order to address
More informationUse of the Booklet Category Test to assess abstract concept formation in schizophrenic disorders
Bond University epublications@bond Humanities & Social Sciences papers Faculty of Humanities and Social Sciences 1-1-2012 Use of the Booklet Category Test to assess abstract concept formation in schizophrenic
More informationThe British Approach to Understanding and Treating Psychosis
The British Approach to Understanding and Treating Psychosis Robin M Murray Professor of Psychiatric Research Department of Psychosis Studies Institute of Psychiatry robin.murray@kcl.ac.uk Which boy will
More informationThe Difficult Patient. Psychiatric Dilemmas in the Primary Care Setting. No Disclosures. Objectives 10/12/17. Erick K. Hung, MD
Psychiatric Dilemmas in the Primary Care Setting No Disclosures Erick K. Hung, MD Associate Professor of Clinical Psychiatry University of California, San Francisco Objectives Describe approaches to the
More informationSuicide, Para suicide and Risk Assessment
Suicide, Para suicide and Risk Assessment LPT Gondar Mental Health Group www.le.ac.uk Objectives: Definition of suicide, Para suicide/dsh Changing trends of methods used Epidemiology Clinical Variables
More informationBeacon Health Strategies Comorbid Mental Health and Substance Use Disorder Screening Program Description
Purpose The purpose of Beacon s Comorbid Mental Health Substance Use Disorder Screening Program is to establish a formal process of assessing and ensuring early detection and treatment cooccurring mental
More informationDBT Modification/ Intervention
Table 2. Published Studies Examining Application of Inpatient DBT (alphabetical listing) Citation Inpatient Setting DBT Sample Comparison Sample DBT Modification/ Intervention Outcome Measures Results
More informationAdult Mental Health Services applicable to Members in the State of Connecticut subject to state law SB1160
Adult Mental Health Services Comparison Create and maintain a document in an easily accessible location on such health carrier's Internet web site that (i) (ii) compares each aspect of such clinical review
More informationSchizophrenia: Early Intervention
Focus on CME at The University of Western Ontario Schizophrenia: Early Intervention Rahul Manchanda, MD, MRCPsych, FRCP(C); and Ross M.G. Norman, PhD, CPsych Presented at A Psychiatric Update 2003, Regional
More informationOne-off assessments within a community mental health team
Primary Care Mental Health 2007;4:00 00 # 2007 Radcliffe Publishing International research One-off assessments within a community mental health team Linda Heaney Consultant Psychiatrist, Avon and Wiltshire
More informationP50 Suppression in Recent-Onset Schizophrenia: Clinical Correlates and Risperidone Effects
Journal of Abnormal Psychology Copyright 1998 by the American Psychological Association, Inc, 1998, Vol. 107, No. 4, 691-698 0021-843X/98/$3.00 P50 Suppression in Recent-Onset Schizophrenia: Clinical Correlates
More informationAggregation of psychopathology in a clinical sample of children and their parents
Aggregation of psychopathology in a clinical sample of children and their parents PA R E N T S O F C H I LD R E N W I T H PSYC H O PAT H O LO G Y : PSYC H I AT R I C P R O B LEMS A N D T H E A S SO C I
More informationThe temporal stability of electrodermal variables over a one-year period in patients with recent-onset schizophrenia and in normal subjects
Psychophysiology, 39 ~2002!, 124 132. Cambridge University Press. Printed in the USA. Copyright 2002 Society for Psychophysiological Research DOI: 10.1017.S0048577201392028 The temporal stability of electrodermal
More informationACUTE INPATIENT TREATMENT
I. Definition of Service: ACUTE INPATIENT TREATMENT Acute inpatient hospitalization represents the most intensive level of psychiatric care. Multidisciplinary assessments and multimodal interventions are
More informationCHAPTER 9.1. Summary
CHAPTER 9.1 Summary 174 TRAUMA-FOCUSED TREATMENT IN PSYCHOSIS Treating PTSD in psychosis The main objective of this thesis was to test the effectiveness and safety of evidence-based trauma-focused treatments
More informationS P O U S A L R ES E M B L A N C E I N PSYCHOPATHOLOGY: A C O M PA R I SO N O F PA R E N T S O F C H I LD R E N W I T H A N D WITHOUT PSYCHOPATHOLOGY
Aggregation of psychopathology in a clinical sample of children and their parents S P O U S A L R ES E M B L A N C E I N PSYCHOPATHOLOGY: A C O M PA R I SO N O F PA R E N T S O F C H I LD R E N W I T H
More informationWith Mild and More Severe Intellectual Disabilities Referred to a Dual Diagnosis Service. Abstract. Authors
brief report: Comparison of Clients With Mild and More Severe Intellectual Disabilities Referred to a Dual Diagnosis Service Abstract Authors Jonny Elserafi, 1,2 Stacy E. White, 1 Yona Lunsky 1,2 1 Dual
More informationCALIFORNIA COUNTIES TREATMENT RECORD REQUIREMENTS
CALIFORNIA COUNTIES TREATMENT RECORD REQUIREMENTS Every service provided is subject to Beacon Health Options, State of California and federal audits. All treatment records must include documentation of
More informationInitial Assessment in Counseling. Chapter 6
Initial Assessment in Counseling Chapter 6 Information Gathered in the Initial Interview Demographic information Client background information Health and medical history Client s Presenting concerns Other
More informationALCOHOL DEPENDENCE SYNDROME AND OTHER PSYCHIATRIC ILLNESSESS
Research article ALCOHOL DEPENDENCE SYNDROME AND OTHER PSYCHIATRIC ILLNESSESS Dr. Amitabh Saha Dept of Psychiatry, Command Hospital Pune -411040 India E-mail: sahaing@gmail.com Abstract Alcohol is the
More information8. DEPRESSION 1. Eve A. Kerr, M.D., M.P.H. and Kenneth A. Clark, M.D., M.P.H.
8. DEPRESSION 1 Eve A. Kerr, M.D., M.P.H. and Kenneth A. Clark, M.D., M.P.H. We relied on the following sources to construct quality indicators for depression: the AHCPR Clinical Practice Guideline in
More information2) Percentage of adult patients (aged 18 years or older) with a diagnosis of major depression or dysthymia and an
Quality ID #370 (NQF 0710): Depression Remission at Twelve Months National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Prevention, Treatment, and Management of Mental Health
More informationMarked increases in psychopathology found in a 30-year cohort comparison of suicide attempters
Psychological Medicine, 2004, 34, 833 841. f 2004 Cambridge University Press DOI: 10.1017/S0033291703001867 Printed in the United Kingdom Marked increases in psychopathology found in a 30-year cohort comparison
More informationPROVIDED IN RESPONSE TO YOUR UNSOLICITED REQUEST FOR INFORMATION
KINECT 2 NCT01733121 Baseline Week 2 Week 4 Week 6 Valbenazine 25-75 mg Valbenazine 40 mg KINECT 3 NCT02274558 Valbenazine 80 mg a KINECT 2 and KINECT 3 were 6-week, double-blind placebo-controlled trials
More informationSuicidality and Older Adults
Suicidality and Older Adults Leo Sher, M.D. Associate Professor of Psychiatry Icahn School of Medicine at Mount Sinai Director, Inpatient Psychiatry James J. Peters Veterans Administration Medical Center
More informationSKILLS TRAINING IN SCHIZOPHRENIA TABLE 1. Baseline Characteristics of Subjects With Schizophrenia or Schizoaffective Disorder Randomly Assigned to Cli
Article Supplementing Clinic-Based Skills Training With Manual- Based Community Support Sessions: Effects on Social Adjustment of Patients With Schizophrenia Shirley M. Glynn, Ph.D. Stephen R. Marder,
More informationDischarges against medical advice
Predictors and Outcome of Discharge Against Medical Advice From the Psychiatric Units of a General Hospital Kenneth P. Pages, M.D. Joan E. Russo, Ph.D. Dane K. Wingerson, M.D. Richard K. Ries, M.D. Peter
More informationAlberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007
Alberta Alcohol and Drug Abuse Commission POSITION ON ADDICTION AND MENTAL HEALTH POSITION The Alberta Alcohol and Drug Abuse Commission (AADAC) recognizes that among clients with addiction problems, there
More informationNovember 2014 MRC2.CORP.X.00004
This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid consultant of Otsuka America Pharmaceutical, Inc. advice or professional diagnosis. Users seeking
More informationDepression in Children with Autism/Pervasive Developmental Disorders: A Case-Control Family History Study
Journal of Autism and Developmental Disorders, Vol 28, No. 2, 1998 Depression in Children with Autism/Pervasive Developmental Disorders: A Case-Control Family History Study Mohammad Ghaziuddin1,2 and John
More informationAPPENDIX 11: CASE IDENTIFICATION STUDY CHARACTERISTICS AND RISK OF BIAS TABLES
APPENDIX 11: CASE IDENTIFICATION STUDY CHARACTERISTICS AND RISK OF BIAS TABLES 1 Study characteristics table... 3 2 Methodology checklist: the QUADAS-2 tool for studies of diagnostic test accuracy... 4
More informationSupplementary Methods
Supplementary Materials for Suicidal Behavior During Lithium and Valproate Medication: A Withinindividual Eight Year Prospective Study of 50,000 Patients With Bipolar Disorder Supplementary Methods We
More information9/16/2016. I would feel comfortable dispensing/prescribing varenicline to a patient with a mental health disorder. Learning Objectives
The Smoking Gun: for Smoking Cessation in Patients with Mental Health Disorders BRENDON HOGAN, PHARMD PGY2 PSYCHIATRIC PHARMACY RESIDENT CTVHCS, TEMPLE, TX 09/23/2016 I would feel comfortable dispensing/prescribing
More informationEarly Intervention Teams services for early psychosis
Early Intervention Teams services for early psychosis Early intervention services work with people who are usually between 14 and 35, and are either at risk of or are currently experiencing a first episode
More informationA Coding System to Measure Elements of Shared Decision Making During Psychiatric Visits
Measuring Shared Decision Making -- 1 A Coding System to Measure Elements of Shared Decision Making During Psychiatric Visits Michelle P. Salyers, Ph.D. 1481 W. 10 th Street Indianapolis, IN 46202 mpsalyer@iupui.edu
More informationEarly Psychosis Services: Philadelphia PEACE Program
Early Psychosis Services: Philadelphia PEACE Program Irene Hurford, M.D. Clinical Director, PEACE Program, Horizon House Assistant Professor, Department of Psychiatry, University of Pennsylvania 1 John
More informationAcute Stabilization In A Trauma Program: A Pilot Study. Colin A. Ross, MD. Sean Burns, MA, LLP
In Press, Psychological Trauma Acute Stabilization In A Trauma Program: A Pilot Study Colin A. Ross, MD Sean Burns, MA, LLP Address correspondence to: Colin A. Ross, MD, 1701 Gateway, Suite 349, Richardson,
More informationCRITICALLY APPRAISED PAPER (CAP)
CRITICALLY APPRAISED PAPER (CAP) Gantman, A., Kapp, S. K., Orenski, K., & Laugeson, E. A. (2012). Social skills training for young adults with high-functioning autism spectrum disorders: A randomized controlled
More informationBroadcastMed Bipolar, Borderline, Both? Diagnostic/Formulation Issues in Mood and Personality Disorders
BroadcastMed Bipolar, Borderline, Both? Diagnostic/Formulation Issues in Mood and Personality Disorders BRIAN PALMER: Hi. My name is Brian Palmer. I'm a psychiatrist here at Mayo Clinic. Today, we'd like
More informationTHE LONG TERM PSYCHOLOGICAL EFFECTS OF DAILY SEDATIVE INTERRUPTION IN CRITICALLY ILL PATIENTS
THE LONG TERM PSYCHOLOGICAL EFFECTS OF DAILY SEDATIVE INTERRUPTION IN CRITICALLY ILL PATIENTS John P. Kress, MD, Brian Gehlbach, MD, Maureen Lacy, PhD, Neil Pliskin, PhD, Anne S. Pohlman, RN, MSN, and
More informationAccurate Diagnosis of Primary Psychotic Disorders
Accurate Diagnosis of Primary Psychotic Disorders The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health Netsmart
More informationPSYCHOPATHOLOGY AND DEVELOPMENT: TRAJECTORIES OF PSYCHOPATHOLOGY FROM EARLY ADOLESCENCE THROUGH YOUNG ADULTHOOD
Psychopathology and Develoment, 1 PSYCHOPATHOLOGY AND DEVELOPMENT: TRAJECTORIES OF PSYCHOPATHOLOGY FROM EARLY ADOLESCENCE THROUGH YOUNG ADULTHOOD Marc S. Schulz*, Stuart T. Hauser**, Joseph P. Allen***,
More informationOffice of Health Equity Advisory Committee Meeting
Office of Health Equity Advisory Committee Meeting Disparities in Mental Health Status and Care Sergio Aguilar-Gaxiola, MD, PhD Professor of Clinical Internal Medicine Director, Center for Reducing Health
More informationPsychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com
Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com Introduction Psychotic spectrum disorders include schizotypal personality disorder, delusional disorder, brief psychotic
More informationCommunity Services - Eligibility
Community Services - Eligibility In order for DMH to reimburse care, the individual must meet both financial and clinical eligibility criteria. These criteria are described in detail in the DMH provider
More informationAntidepressants for treatment of depression.
JR3 340 1 of 9 PSYCHOTROPIC MEDICATIONS PURPOSE The use of psychotropic medication as part of a youth's comprehensive mental health treatment plan may be beneficial. The administration of psychotropic
More informationA Pilot Study of Interpersonal Psychotherapy for Depressed Women with Breast Cancer
A Pilot Study of Interpersonal Psychotherapy for Depressed Women with Breast Cancer CARLOS BLANCO, M.D., Ph.D.* JOHN C. MARKOWITZ, M.D.* DAWN L. HERSHMAN, M.D., M.S.# JON A. LEVENSON, M.D.* SHUAI WANG,
More informationBecause of the many changes in
Hospitalization and Pharmacotherapy for Borderline Personality Disorder in a Psychiatric Emergency Service Juan C. Pascual, M.D. David Córcoles, M.D. Juan Castaño, M.D. Jose M. Ginés, M.D. Alfredo Gurrea,
More informationdiagnostic consistency in catatonic schizophrenia
ISSUE NO. 11, WINTER 1974 103 diagnostic consistency in catatonic schizophrenia Frederick G. Guggenheim and Haroutun M. Babigian Two basic methods have been used to study consistency in diagnosing schizophrenia:
More informationEarly Stages of Psychosis. Learning Objectives
Early Stages of Psychosis Stephan Heckers, MD MSc Department of Psychiatry and Behavioral Sciences Vanderbilt University Learning Objectives Summarize the five domains of psychosis Describe how psychotic
More informationCognitive-Behavioral Assessment of Depression: Clinical Validation of the Automatic Thoughts Questionnaire
Journal of Consulting and Clinical Psychology 1983, Vol. 51, No. 5, 721-725 Copyright 1983 by the American Psychological Association, Inc. Cognitive-Behavioral Assessment of Depression: Clinical Validation
More informationDo Violent Offenders With Schizophrenia Who Attack Family Members Differ From Those With Other Victims?
International Journal of Forensic Mental Health 2003, Vol. 2, No. 2, pages 195-200 Do Violent Offenders With Schizophrenia Who Attack Family Members Differ From Those With Other Victims? Annika Nordström
More informationPSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE
PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE Introduction and General Principles April 2017 Adapted for New Mexico from with permission from the Texas Department
More informationMay and Klonsky s (2016) meta-analysis of factors
COMMENTARY Moving Toward an Ideation-to-Action Framework in Suicide Research: A Commentary on May and Klonsky (2016) Taylor A. Burke and Lauren B. Alloy, Temple University Key words: commentary, meta-analysis,
More informationInpatient Psychiatric Services for Under Age 21 Manual. Acute Inpatient Mental Health (Child/Adolescent)
Inpatient Psychiatric Services for Under Age 21 Manual Acute Inpatient Mental Health (Child/Adolescent) Description of Services: Acute inpatient mental health treatment represents the most intensive level
More informationProceedings of the International Conference on RISK MANAGEMENT, ASSESSMENT and MITIGATION
COGNITIVE-BEHAVIOURAL THERAPY EFFICACY IN MAJOR DEPRESSION WITH ASSOCIATED AXIS II RISK FACTOR FOR NEGATIVE PROGNOSIS DANIEL VASILE*, OCTAVIAN VASILIU** *UMF Carol Davila Bucharest, ** Universitary Military
More informationOutline of content of Mindfulness-based Psychoeducation Program
Data Supplement for Chien et al. (10.1176/appi.ps.201200209) Appendix Outline of content of Mindfulness-based Psychoeducation Program Introduction The Mindfulness-based Psychoeducation Program (MBPP) consists
More informationOccupational Therapy for First Episode Psychosis
2018 International OT Conference Occupational Therapy for First Episode Psychosis Ms. Yeung Sau Fong, Odelia Occupational Therapy Department Kwai Chung Hospital HKSAR Early intervention Stage specific
More information